Chardan Capital Has Pessimistic View of COYA FY2025 Earnings
Coya Therapeutics, Inc. (NASDAQ:COYA – Free Report) – Research analysts at Chardan Capital lowered their FY2025 earnings per share estimates for Coya Therapeutics in a note issued to investors on Wednesday, May 14th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($1.57) for the year, down from […]
Coya Therapeutics, Inc. (NASDAQ:COYA – Free Report) – Research analysts at Chardan Capital lowered their FY2025 earnings per share estimates for Coya Therapeutics in a note issued to investors on Wednesday, May 14th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($1.57) for the year, down from […]
